Immunocore

London Exchange

Malin Corporation’s investee Immunocore prices upsized Nasdaq IPO
ByNNR February 5, 2021October 24, 2023

DUBLIN: Malin Corporation notes that its investee company, Immunocore, has announced the pricing of its initial public offering (IPO) of 9.9 million American Depositary Shares (ADSs) representing 9.9 million ordinary shares at an initial public offering price of $26 per…

Read More Malin Corporation’s investee Immunocore prices upsized Nasdaq IPO
London Exchange

Schroder to sell £49.0 million worth of assets to Rosetta Capital
ByNNR January 27, 2021October 24, 2023

LONDON: Schroder UK Public Private Trust has signed a sale and purchase agreement for the sale of a basket of seven assets to Rosetta Capital VI, LP, an investment fund managed by the UK-based life science venture capital firm Rosetta…

Read More Schroder to sell £49.0 million worth of assets to Rosetta Capital

Exit mobile version